The role of microglial cells in amyotrophic lateral sclerosis

Physical Medicine and Rehabilitation Clinics of North America

Volumn 16, Issue 4, 2005, Pages 1081-1090

  Weydt, Patrick ^a   Möller, Thomas ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; MINOCYCLINE;

AMYOTROPHIC LATERAL SCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; HUMAN; INFLAMMATION; MEDIATOR RELEASE; MICROGLIA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICROGLIA; MOTOR NEURONS;

EID: 26244449450     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmr.2005.08.021     Document Type: Review

References (69)

1. L.I. Brujin, T.M. Miller, and D.W. Cleveland Unraveling the mechanisms involved in motor neuron degeneration in ALS Annu Rev Neurosci 27 2004 723
2. M.J. Strong The basic aspects of therapeutics in amyotrophic lateral sclerosis Pharmacol Ther 98 2003 379
3. L.P. Rowland, and N.A. Shneider Amyotrophic lateral sclerosis N Engl J Med 344 2001 1688
4. R.H. Brown, V. Meininger, and M. Swash Amyotrophic lateral sclerosis R.H. Brown V. Meininger M. Swash Amyotrophic lateral sclerosis 2000 Martin Dunitz London
5. D.R. Rosen, T. Siddique, and D. Patterson Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 362 1993 59
6. J.R. Subramaniam, W.E. Lyons, and J. Liu Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading Nat Neurosci 5 2002 301
7. D.W. Cleveland, and J.D. Rothstein From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS Nat Rev Neurosci 2 2001 806
8. L.I. Bruijn, M.W. Becher, and M.K. Lee ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions Neuron 18 1997 327
9. M.E. Gurney Transgenic animal models of amyotrophic lateral sclerosis R.H. Brown V. Meininger M. Swash Amyotrophic lateral sclerosis 2000 Martin Dunitz London 251
10. M.E. Gurney, H. Pu, and A.Y. Chiu Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation Science 264 1994 1772
11. D.S. Howland, J. Liu, and Y. She Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1mutant-mediated amyotrophic lateral sclerosis (ALS) Proc Natl Acad Sci U S A 99 2002 1604
12. M. Nagai, M. Aoki, and I. Miyoshi Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease J Neurosci 21 2001 9246
13. W.J. Streit Microglia as neuroprotecitve, immunocompetent cells of the CNS Glia 40 2002 133
14. G.W. Kreutzberg Microglia: a sensor for pathological events in the CNS Trends Neurosci 19 1996 312
15. D. Davalos, J. Grutzendler, and G. Yang ATP mediates rapid microglial response to local brain injury in vivo Nat Neurosci 8 2005 752
16. L. Fetler, and S. Amigorena Neuroscience: brain under surveillance. The microglia patrol Science 309 2005 392
17. A. Nimmerjahn, F. Kirchhoff, and F. Helmchen Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo Science 308 2005 1314
18. U.K. Hanisch Microglia as a source and target of cytokines Glia 40 2002 140
19. M.J. Carson Microglia as liaisons between the immune and central nervous system: functional implications in multiple sclerosis Glia 40 2002 218
20. G.A. Garden Microglia in human immunodeficiency virus-associated neurodegeneration Glia 40 2002 240
21. T. Wyss-Coray, and L. Mucke Inflammation in neurodegenerative disease: a double-edged sword Neuron 35 2002 419
22. P. Eikelenboom, C. Bate, and W.A. Van Gool Neuroinflammation in Alzheimer's disease and prion disease Glia 40 2002 232
23. E.G. McGeer, and P.L. McGeer Brain inflammation in Alzheimer disease and the therapeutic implications Curr Pharm Des 5 1999 821
24. M.L. Monje, H. Toda, and T.D. Palmer Inflammatory blockade restores adult hippocampal neurogenesis Science 302 2003 1760
25. G. Almer, C. Guegan, and P. Teismann Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis Ann Neurol 49 2001 176
26. J.L. Elliott Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis Brain Res Mol Brain Res 95 2001 172
27. K. Hensley, R.A. Floyd, and B. Gordon Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis J Neurochem 82 2002 365
28. M.D. Nguyen, J.P. Julien, and S. Rivest Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration Ann Neurol 50 2001 630
29. M.K. Olsen, S.L. Roberds, and B.R. Ellerbrock Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord Ann Neurol 50 2001 730
30. Y. Xie, P. Weydt, and D.S. Howland Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 rats Neuroreport 15 2004 2513
31. T. Yoshihara, S. Ishigaki, and M. Yamamoto Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis J Neurochem 80 2002 158
32. M.E. Alexianu, M. Kozovska, and S.H. Appel Immune reactivity in a mouse model of familial ALS correlates with disease progression Neurology 57 2001 1282
33. J.I. Engelhardt, J. Tajti, and S.H. Appel Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis Arch Neurol 50 1993 30
34. T. Kawamata, H. Akiyama, and T. Yamada Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue Am J Pathol 140 1992 691
35. Y. Dong, and E.N. Benveniste Immune function of astrocytes Glia 36 2001 180
36. H. Neumann Control of glial immune function by neurons Glia 36 2001 191
37. G. Almer, S. Vukosavic, and N. Romero Inducible nitric oxide synthase upregulation in a transgenic model of familial amyotrophic lateral sclerosis J Neurochem 72 1999 2415
38. E.D. Hall, J.A. Oostveen, and M.E. Gurney Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS Glia 23 1998 249
39. R. Mariotti, and M. Bentivoglio Activation and response to axotomy of microglia in the facial motor nuclei of G93A superoxide dismutase transgenic mice Neurosci Lett 285 2000 87
40. P. Weydt, M.D. Weiss, and T. Moller Neuro-inflammation as a therapeutic target in amyotrophic lateral sclerosis Curr Opin Investig Drugs 3 2002 1720
41. P. Weydt, E.C. Yuen, and B.R. Ransom Increased cytotoxic potential of microglia from ALS-transgenic mice Glia 48 2004 179
42. P.G. Ince, P.J. Shaw, and J.Y. Slade Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes Acta Neuropathol (Berl) 92 1996 395
43. M.R. Turner, A. Cagnin, and F.E. Turkheimer Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study Neurobiol Dis 15 2004 601
44. R. Zhang, R. Gascon, and R.G. Miller Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS) J Neuroimmunol 159 2005 215
45. M. Fiala, Q.N. Liu, and J. Sayre Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier Eur J Clin Invest 32 2002 360
46. Y.H. Gong, A.S. Parsadanian, and A. Andreeva Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration J Neurosci 20 2000 660
47. M.M. Lino, C. Schneider, and P. Caroni Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease J Neurosci 22 2002 4825
48. A. Pramatarova, J. Laganiere, and J. Roussel Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment J Neurosci 21 2001 3369
49. A.M. Clement, M.D. Nguyen, and E.A. Roberts Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice Science 302 2003 113
50. C. Raoul, A.G. Estevez, and H. Nishimune Motoneuron death triggered by a specific pathway downstream of Fas potentiation by ALS-linked SOD1 mutations Neuron 35 2002 1067
51. D. Trotti, A. Rolfs, and N.C. Danbolt SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter Nat Neurosci 2 1999 427 [Erratum appears in Nat Neurosci 1999;2(9):848.]
52. Cleveland DW. Presidential symposium: from Charcot to Lou Gehrig. Motor neuron growth and death. Presented at the 34th Annual Meeting of the Society for Neuroscience. San Diego, October 24, 2004.
53. J. Wang, G. Xu, and H.H. Slunt Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA Neurobiol Dis 2005 in press
54. F. Lopez-Redondo, K. Nakajima, and S. Honda Glutamate transporter GLT-1 is highly expressed in activated microglia following facial nerve axotomy Brain Res Mol Brain Res 76 2000 429
55. K.H. Plate, H. Beck, and S. Danner Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct J Neuropathol Exp Neurol 58 1999 654
56. J.M. Drazen COX-2 inhibitors: a lesson in unexpected problems N Engl J Med 352 2005 1131
57. D.B. Drachman, K. Frank, and M. Dykes-Hoberg Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS Ann Neurol 52 2002 771
58. M. Kiaei, K. Kipiani, and S. Petri Integrative role of cPLA with COX-2 and the effect of non-steroidal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis J Neurochem 93 2005 403
59. P. Klivenyi, G. Gardian, and N.Y. Calingasan Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease J Mol Neurosci 21 2003 191
60. C. Consilvio, A.M. Vincent, and E.L. Feldman Neuroinflammation, COX-2, and ALS: a dual role? Exp Neurol 187 2004 1
61. P.N. Pompl, L. Ho, and M. Bianchi A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis FASEB J 17 2003 725
62. T. Tikka, B.L. Fiebich, and G. Goldsteins Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia J Neurosci 21 2001 2580
63. T. Tikka, T. Usenius, and M. Tenhunen Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation J Neurochem 78 2001 1409
64. T.M. Tikka, and J.E. Koistinaho Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia J Immunol 166 2001 7527
65. M. Domercq, and C. Matute Neuroprotection by tetracyclines Trends Pharmacol Sci 25 2004 609
66. J. Kriz, M. Nguyen, and J. Julien Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis Neurobiol Dis 10 2002 268
67. L. Van Den Bosch, P. Tilkin, and G. Lemmens Minocycline delays disease onset and mortality in a transgenic model of ALS Neuroreport 13 2002 1067
68. S. Zhu, I.G. Stavrovskaya, and M. Drozda Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice Nature 417 2002 74
69. P.H. Gordon, D.H. Moore, and D.F. Gelinas Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis Neurology 62 2004 1845